Y Intercept Hong Kong Ltd Purchases 11,954 Shares of Cencora, Inc. $COR

Y Intercept Hong Kong Ltd grew its holdings in shares of Cencora, Inc. (NYSE:COR) by 40.9% in the 1st quarter, Holdings Channel.com reports. The firm owned 41,203 shares of the company’s stock after purchasing an additional 11,954 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Cencora were worth $12,944,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its position in Cencora by 57.3% during the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 186,732 shares of the company’s stock valued at $58,660,000 after buying an additional 68,055 shares during the period. Elevation Point Wealth Partners LLC grew its position in shares of Cencora by 397.1% during the 1st quarter. Elevation Point Wealth Partners LLC now owns 14,641 shares of the company’s stock valued at $4,599,000 after acquiring an additional 11,696 shares during the period. Blue Capital Inc. purchased a new stake in shares of Cencora in the 1st quarter worth $240,000. Keybank National Association OH increased its stake in shares of Cencora by 21.7% in the 1st quarter. Keybank National Association OH now owns 17,702 shares of the company’s stock worth $5,561,000 after purchasing an additional 3,159 shares in the last quarter. Finally, Twin City Private Wealth LLC raised its holdings in Cencora by 3.8% in the 1st quarter. Twin City Private Wealth LLC now owns 2,549 shares of the company’s stock worth $801,000 after purchasing an additional 93 shares during the period. Institutional investors own 97.52% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on COR. Leerink Partners reiterated an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Wells Fargo & Company decreased their price objective on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. Evercore set a $360.00 price objective on Cencora in a research report on Wednesday, April 8th. Bank of America lifted their price objective on Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Finally, Morgan Stanley set a $342.00 price objective on Cencora in a research note on Friday, May 8th. Eleven analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $367.75.

Cencora Price Performance

COR stock opened at $296.43 on Friday. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The company’s fifty day moving average price is $278.14 and its 200-day moving average price is $320.54. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The company has a market capitalization of $57.67 billion, a PE ratio of 22.73, a price-to-earnings-growth ratio of 1.60 and a beta of 0.58.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business’s revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the business posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts anticipate that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio is 18.40%.

Cencora declared that its Board of Directors has approved a share repurchase plan on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s management believes its shares are undervalued.

Insider Buying and Selling at Cencora

In other news, Director Lauren M. Tyler acquired 550 shares of the business’s stock in a transaction dated Monday, June 22nd. The stock was purchased at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the transaction, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.38% of the stock is currently owned by insiders.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.